Literature DB >> 22000473

Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation.

K Brown1, D S Heller, S Zamudio, N P Illsley.   

Abstract

Conflicting information regarding expression of GLUT3 protein in the human placenta has been reported and the localization and pattern of expression of GLUT3 protein across gestation has not been clearly defined. The objective of this study was characterization of syncytial GLUT3 protein expression across gestation. We hypothesized that GLUT3 protein is present in the syncytial microvillous membrane and that its expression decreases over gestation. GLUT3 protein was measured in samples from a range of gestational ages (first to third trimester), with human brain and human bowel used as a positive and negative control respectively. As an additional measure of specificity, we transfected BeWo choriocarcinoma cells, a trophoblast cell line expressing GLUT3, with siRNA directed against GLUT3 and analyzed expression by Western blotting. GLUT3 was detected in the syncytiotrophoblast at all gestational ages by immunohistochemistry. Using Western blotting GLUT3 was detected as an integral membrane protein at a molecular weight of ∼50 kDa in microvillous membranes from all trimesters but not in syncytial basal membranes. The identity of the primary antibody target was confirmed by demonstrating that expression of the immunoblotting signal in GLUT3 siRNA-treated BeWo was decreased to 18 ± 6% (mean ± SEM) of that seen in cells transfected with a non-targeting siRNA. GLUT3 expression in microvillous membranes detected by Western blot decreased through the trimesters such that expression in the second trimester (wks 14-26) was 48 ± 7% of that in the first trimester and by the third trimester (wks 31-40) only 34 ± 10% of first trimester expression. In addition, glucose uptake into BeWo cells treated with GLUT3 siRNA was reduced to 60% of that measured in cells treated with the non-targeting siRNA. This suggests that GLUT3-mediated uptake comprises approximately 50% of glucose uptake into BeWo cells. These results confirm the hypothesis that GLUT3 is present in the syncytial microvillous membrane early in gestation and decreases thereafter, supporting the idea that GLUT3 is of greater importance for glucose uptake early in gestation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22000473      PMCID: PMC3272879          DOI: 10.1016/j.placenta.2011.09.014

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  39 in total

1.  Asymmetric syncytial expression of GLUT9 splice variants in human term placenta and alterations in diabetic pregnancies.

Authors:  Kristin P Bibee; Nicholas P Illsley; Kelle H Moley
Journal:  Reprod Sci       Date:  2010-10-06       Impact factor: 3.060

2.  GLUT12 expression in human placenta in first trimester and term.

Authors:  N M Gude; J L Stevenson; S Rogers; J D Best; B Kalionis; M A Huisman; J J H M Erwich; A Timmer; R G King
Journal:  Placenta       Date:  2003-05       Impact factor: 3.481

3.  Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos.

Authors:  S Nagamatsu; H Sawa; N Inoue; Y Nakamichi; H Takeshima; T Hoshino
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

4.  Tissue distribution of the human GLUT3 glucose transporter.

Authors:  R S Haber; S P Weinstein; E O'Boyle; S Morgello
Journal:  Endocrinology       Date:  1993-06       Impact factor: 4.736

5.  Developmental expression of Glut1 glucose transporter and c-fos genes in human placental cells.

Authors:  S Hauguel-de Mouzon; A Leturque; E Alsat; M Loizeau; D Evain-Brion; J Girard
Journal:  Placenta       Date:  1994-01       Impact factor: 3.481

6.  An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies.

Authors:  A M Marconi; I Cetin; E Davoli; A M Baggiani; R Fanelli; P V Fennessey; F C Battaglia; G Pardi
Journal:  Metabolism       Date:  1993-07       Impact factor: 8.694

7.  Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation.

Authors:  T Jansson; M Wennergren; N P Illsley
Journal:  J Clin Endocrinol Metab       Date:  1993-12       Impact factor: 5.958

8.  Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain.

Authors:  G J Mantych; D E James; H D Chung; S U Devaskar
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

9.  Characterization of GLUT3 protein expressed in Chinese hamster ovary cells.

Authors:  T Asano; H Katagiri; K Takata; K Tsukuda; J L Lin; H Ishihara; K Inukai; H Hirano; Y Yazaki; Y Oka
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

10.  Distribution of GLUT3 glucose transporter protein in human tissues.

Authors:  P R Shepherd; G W Gould; C A Colville; S C McCoid; E M Gibbs; B B Kahn
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

View more
  28 in total

1.  Human placental GLUT1 glucose transporter expression and the fetal insulin-like growth factor axis in pregnancies complicated by diabetes.

Authors:  Marcus H Borges; Janet Pullockaran; Patrick M Catalano; Marc U Baumann; Stacy Zamudio; Nicholas P Illsley
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-05       Impact factor: 5.187

2.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

3.  Insulin stimulates GLUT4 trafficking to the syncytiotrophoblast basal plasma membrane in the human placenta.

Authors:  Laura B James-Allan; Jaron Arbet; Stephanie B Teal; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-05-21       Impact factor: 5.958

Review 4.  Impact of gestational diabetes mellitus in the maternal-to-fetal transport of nutrients.

Authors:  João Ricardo Araújo; Elisa Keating; Fátima Martel
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

Review 5.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

6.  Chorionic somatomammotropin impacts early fetal growth and placental gene expression.

Authors:  K M Jeckel; A C Boyarko; G J Bouma; Q A Winger; R V Anthony
Journal:  J Endocrinol       Date:  2018-04-16       Impact factor: 4.286

7.  Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction.

Authors:  Karen J Gibbins; Katherine N Gibson-Corley; Ashley S Brown; Matthew Wieben; Richard C Law; Camille M Fung
Journal:  Biol Reprod       Date:  2018-05-01       Impact factor: 4.285

8.  Genetic variations in the GLUT3 gene associated with myelomeningocele.

Authors:  Brendan D Connealy; Hope Northrup; Kit Sing Au
Journal:  Am J Obstet Gynecol       Date:  2014-05-09       Impact factor: 8.661

Review 9.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

10.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.